Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Touchstone International Medical Science Co's EBIT per Share for the
three
months ended in Mar. 2026 was ¥0.12.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ¥1.12.
During the past 12 months, the average EBIT per Share Growth Rate of Touchstone International Medical Science Co was 50.50% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 30.50% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 15.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
SHSE:688013'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -17 Med: -1.3 Max: 30.5
Current: 30.5
During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of Touchstone International Medical Science Co was 30.50% per year. The lowest was -17.00% per year. And the median was -1.30% per year.
SHSE:688013's 3-Year EBIT Growth Rate is ranked better than 75.73% of 684
companies
in the Medical Devices & Instruments industry
Industry Median: 9.6
vs SHSE:688013: 30.50
Touchstone International Medical Science Co (SHSE:688013) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Touchstone International Medical Science Co EBIT per Share Related Terms
Touchstone International Medical Science Co EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Touchstone International Medical Science Co EBIT per Share Chart
Touchstone International Medical Science Co Annual Data
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.12
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Touchstone International Medical Science Co (SHSE:688013) has a EBIT per Share of ¥1.12 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Touchstone International Medical Science Co and its competitors. According to the industry distribution chart, Touchstone International Medical Science Co ranks #166 out of 684 companies in the Medical Devices & Instruments industry, placing it in the top 24.3%.
Is Touchstone International Medical Science Co's EBIT per Share too high?
Touchstone International Medical Science Co's current EBIT per Share is ¥1.12. Based on the distribution chart, Touchstone International Medical Science Co ranks #166 out of 684 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Touchstone International Medical Science Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Touchstone International Medical Science Co's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Touchstone International Medical Science Co ranks #166 out of 684 companies for EBIT per Share. This places Touchstone International Medical Science Co in the top 24% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.60, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Touchstone International Medical Science Co and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Touchstone International Medical Science Co's current EBIT per Share is ¥1.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Touchstone International Medical Science Co stock overvalued right now?
Based on GuruFocus' analysis, Touchstone International Medical Science Co (SHSE:688013) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥28.55, compared to a current price of ¥22.61 — trading 20.8% below its estimated fair value. The current EBIT per Share is ¥1.12. Touchstone International Medical Science Co's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Touchstone International Medical Science Co (SHSE:688013), the current EBIT per Share is ¥1.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Touchstone International Medical Science Co (SHSE:688013) Overvalued in 2026?
Based on GuruFocus' analysis, Touchstone International Medical Science Co stock appears to be undervalued.
The current stock price of ¥22.61 is trading 20.8% below its estimated GF Value™ of ¥28.55.
GuruFocus considers Touchstone International Medical Science Co to be Modestly Undervalued.
Key valuation signals for SHSE:688013:
EBIT per Share: ¥1.12
GF Value™: ¥28.55 vs. price of ¥22.61 (20.8% below fair value)
No single metric tells the full story. See the SHSE:688013 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Touchstone International Medical Science Co Business Description
Touchstone International Medical Science Co Ltd is specialized in the development of surgical staplers that enhance clinical performance, minimise risk and improve patient outcomes. The company's products include Auto Purse String Clamp for Single Use (APS); Intraluminal Stapler for Single Use (CSC&ECSC); Endoscopic Linear Cutter and Single Use Loading Unit (ELC&ELCC); Intraluminal Stapler for Single Use (KOL); Linear Cutter and Reloads (LC&LCC); Linear Stapler and Reloads (LS&LSC); PPH Stapler and Purse Sets for Single Use (PPH); Tissue - Selecting Therapy Stapler (TST33); Tissue - Selecting Therapy Stapler (TST36); and Tissue - Selecting Therapy Stapler (Proctology Examination Kit).
83GF Score
Get the complete analysis for SHSE:688013
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688013 has been successfully added to your 
